18F-fluorodeoxyglucose-positron emission tomography scanning is more useful in followup than in the initial assessment of patients with Erdheim-Chester disease

Arthritis and Rheumatism

Volumn 60, Issue 10, 2009, Pages 3128-3138

  Arnaud, Laurent ^a   Malek, Zoulikha ^a   Archambaud, Frédérique ^a   Kas, Aurélie ^a   Toledano, Dan ^a   Drier, Aurélie ^a   Zeitoun, Delphine ^a   Cluzel, Philippe ^a   Grenier, Philippe A ^a   Chiras, Jacques ^a   Piette, Jean Charles ^a   Amoura, Zahir ^a   Haroche, Julien ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; FLUORODEOXYGLUCOSE F 18; IMATINIB; PAMIDRONIC ACID; PEGINTERFERON; PREDNISONE; DIAGNOSTIC AGENT;

ADULT; AGED; ARTICLE; CARDIOVASCULAR SYSTEM; CENTRAL NERVOUS SYSTEM; CLINICAL ARTICLE; COHORT ANALYSIS; COMPUTED TOMOGRAPHY SCANNER; CONTROLLED STUDY; DIAGNOSTIC VALUE; ERDHEIM CHESTER DISEASE; FEMALE; FOLLOW UP; HUMAN; IMAGE ANALYSIS; IMMUNOMODULATION; INTERMETHOD COMPARISON; MALE; MEDICAL SPECIALIST; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MEDICINE; PATIENT ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; TREATMENT RESPONSE; WHOLE BODY PET; WHOLE BODY SCANNER; HOSPITALIZATION; METHODOLOGY; MIDDLE AGED; OBSERVER VARIATION; POSITRON EMISSION TOMOGRAPHY; SCINTISCANNING; WHOLE BODY IMAGING;

ADULT; AGED; COHORT STUDIES; ERDHEIM-CHESTER DISEASE; FEMALE; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; OBSERVER VARIATION; POSITRON-EMISSION TOMOGRAPHY; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; WHOLE BODY IMAGING;

EID: 70349774433     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.24848     Document Type: Article

References (28)

1. Chester W. Uber lipoidgranulomatose. Virchows Arch Pathol Anat 1930;279:561-602.
2. Veyssier-Belot C, Cacoub P, Caparros-Lefebvre D, Wechsler J, Brun B, Remy M, et al. Erdheim-Chester disease: clinical and radiologic characteristics of 59 cases. Medicine (Baltimore) 1996; 75:157-169 (Pubitemid 26159212)
3. Haroche J, Amoura Z, Dion E, Wechsler B, Costedoat- Chalumeau N, Cacoub P, et al. Cardiovascular involvement, an overlooked feature of Erdheim-Chester disease: report of 6 new cases and a literature review. Medicine (Baltimore) 2004;83: 371-392 (Pubitemid 39541113)
4. Lachenal F, Cotton F, Desmurs-Clavel H, Haroche J, Taillia H, Magy N, et al. Neurological manifestations and neuroradiological presentation of Erdheim-Chester disease: report of 6 cases and systematic review of the literature. J Neurol 2006;253:1267-1277 (Pubitemid 44691550)
5. Juweid ME, Cheson BD. Positron-emission tomography and assessment of cancer therapy. N Engl J Med 2006;354:496-507. (Pubitemid 43200300)
6. Blockmans D, de Ceuninck L, Vanderschueren S, Knockaert D, Mortelmans L, Bobbaers H. Repetitive 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a prospective study of 35 patients. Arthritis Rheum 2006;55:131-137 (Pubitemid 43235138)
7. Bohlega S, Alwatban J, Tulbah A, Bakheet SM, Powe J. Cerebral manifestation of Erdheim-Chester disease: clinical and radiologic findings. Neurology 1997;49:1702-1705 (Pubitemid 28015143)
8. Girszyn N, Arnaud L, Villain D, Kahn JE, Piette AM, Bletry O. Usefulness of combined positron emission tomography and computed tomography imaging in Erdheim-Chester disease. Rev Med Interne 2007;28:770-4. In French.
9. Lin E. FDG PET/CT for biopsy guidance in Erdheim-Chester disease. Clin Nucl Med 2007;32:860-861 (Pubitemid 350303834)
10. Namwongprom S, Nunez R, Kim EE, Macapinlac HA. Tc-99m MDP bone scintigraphy and positron emission tomography/ computed tomography (PET/CT) imaging in Erdheim-Chester disease. Clin Nucl Med 2007;32:35-38 (Pubitemid 46360591)
11. Pereira Neto CC, Roman C, Johnson M, Jagasia M, Martin WH, Delbeke D. Positron emission tomography/computed tomography of a rare xanthogranulomatous process: Erdheim-Chester disease. Mol Imaging Biol 2004;6:63-67 (Pubitemid 38240360)
12. Salsano E, Savoiardo M, Nappini S, Maderna E, Pollo B, Chinaglia D, et al. Late-onset sporadic ataxia, pontine lesion, and retroperitoneal fibrosis: a case of Erdheim-Chester disease. Neurol Sci 2008;29:263-267
13. Haroche J, Amoura Z, Charlotte F, Salvatierra J, Wechsler B, Graux C, et al. Imatinib mesylate for platelet-derived growth factor receptor-β- positive Erdheim-Chester histiocytosis. Blood 2008;111:5413-5415
14. Haroche J, Amoura Z, Wechsler B, Veyssier-Belot C, Charlotte F, Piette JC. Erdheim-Chester disease. Presse Med 2007;36:1663-8. In French.
15. 18F-fluorodeoxyglucose positron emission tomography scanning a reliable way to assess disease activity in Takayasu arteritis? Arthritis Rheum 2009;60:1193-1200
16. Braiteh F, Boxrud C, Esmaeli B, Kurzrock R. Successful treatment of Erdheim-Chester disease, a non-Langerhans-cell histiocytosis, with interferon-α. Blood 2005;106:2992-2994 (Pubitemid 41565890)
17. Haroche J, Amoura Z, Trad SG, Wechsler B, Cluzel P, Grenier PA, et al. Variability in the efficacy of interferon-α in Erdheim- Chester disease by patient and site of involvement: results in eight patients. Arthritis Rheum 2006;54:3330-3336 (Pubitemid 44622105)
18. Nakahara T, Suzuki T, Uno K, Joishi D, Tanaka C, Hashimoto J, et al. 18F-FDG positron emission tomographic imaging in Erdheim-Chester disease with skeletal and extra-skeletal involvement. Leuk Lymphoma 2006;47:935-937 (Pubitemid 43840656)
19. Dion E, Graef C, Miquel A, Haroche J, Wechsler B, Amoura Z, et al. Bone involvement in Erdheim-Chester disease: imaging findings including periostitis and partial epiphyseal involvement. Radiology 2006;238:632-639 (Pubitemid 43134376)
20. 18F-FDG PET in neurodegenerative Langerhans cell histiocytosis: results and potential interest for an early diagnosis of the disease. J Neurol 2008;255:575-580
21. Fenchel M, Doering J, Seeger A, Kramer U, Rittig K, Klumpp B, et al. Ultrafast whole-body MR angiography with two-dimensional parallel imaging at 3.0 T: feasibility study. Radiology 2009;250: 254-263
22. Dion E, Graef C, Haroche J, Renard-Penna R, Cluzel P, Wechsler B, et al. Imaging of thoracoabdominal involvement in Erdheim- Chester disease. AJR Am J Roentgenol 2004;183:1253-1260 (Pubitemid 44210586)
23. Phillips M, Allen C, Gerson P, McClain K. Comparison of FDG-PET scans to conventional radiography and bone scans in management of Langerhans cell histiocytosis. Pediatr Blood Cancer 2009;52:97-101.
24. 18F-FDG PET/CT in sarcoidosis management: review and report of 20 cases. Eur J Nucl Med Mol Imaging 2008;35:1537-1543
25. Al-Quran S, Reith J, Bradley J, Rimsza L. Erdheim-Chester disease: case report, PCR-based analysis of clonality, and review of literature. Mod Pathol 2002;15:666-672
26. Chetritt J, Paradis V, Dargere D, Adle-Biassette H, Maurage CA, Mussini JM, et al. Chester-Erdheim disease: a neoplastic disorder. Hum Pathol 1999;30:1093-1096
27. Favara BE, Feller AC, Pauli M, Jaffe ES, Weiss LM, Arico M, et al. Contemporary classification of histiocytic disorders. Med Pediatr Oncol 1997;29:157-166
28. Stoppacciaro A, Ferrarini M, Salmaggi C, Colarossi C, Praderio L, Tresoldi M, et al. Immunohistochemical evidence of a cytokine and chemokine network in three patients with Erdheim-Chester disease: implications for pathogenesis. Arthritis Rheum 2006;54: 4018-4022 (Pubitemid 44955906)